David M. Stark

Mr. Stark was appointed Teva Pharmaceuticals’ group executive vice president and chief legal officer, and a member of the Teva Executive Committee, in November 2016.

During 2015 and 2016, Mr. Stark served as Teva’s acting chief legal officer, in addition to continuing in his role as the lead lawyer for each of Teva’s two main commercial business units (Global Specialty Medicines and Global Generic Medicines).

Prior to joining Teva, Mr. Stark served as an associate at Willkie Farr & Gallagher (1998–2002), Chadbourne & Parke (1997–1998), and Haight, Gardner, Poor & Havens (1994–1997). Mr. Stark earned his J.D. from New York University School of Law and his B.A. in political science from Northeastern University, summa cum laude. He is a member of the association board of Cold Spring Harbor Laboratory and has served on boards and committees of The Franklin Institute, City Year Greater Philadelphia, and the Association of the Bar of the City of New York.

Bio last updated in June 2021.